Jason Mills

Stock Analyst at Canaccord Genuity

(3.13)
# 1,195
Out of 4,734 analysts
116
Total ratings
69.89%
Success rate
35.01%
Average return

Stocks Rated by Jason Mills

Penumbra
Dec 9, 2024
Maintains: Buy
Price Target: $260$323
Current: $268.20
Upside: +20.43%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $56.73
Upside: +92.14%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $23.01
Upside: +286.79%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $11.94
Upside: +134.51%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $108.71
Upside: +151.13%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $104.40
Upside: -47.32%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $2.24
Upside: +257.14%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $4.68
Upside: +3,169.23%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $99.65
Upside: -69.89%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $604.12
Upside: -60.00%
Maintains: Hold
Price Target: $66$50
Current: $49.21
Upside: +1.61%
Maintains: Buy
Price Target: $41$45
Current: $39.63
Upside: +13.55%
Maintains: Buy
Price Target: $85$62
Current: $17.75
Upside: +249.30%
Maintains: Buy
Price Target: $43$46
Current: $100.91
Upside: -54.41%
Upgrades: Buy
Price Target: n/a
Current: $92.41
Upside: -
Downgrades: Hold
Price Target: $516,000$120,000
Current: $0.56
Upside: +21,420,821.10%